Guidelines developed under pressure. The case of the COVID-19 low-quality “rapid” guidelines and potential solutions

The COVID-19 global pandemic led to a substantial investment into the funding, execution, and publication/dissemination of research at unprecedented speeds and volumes. This, in turn, has created an urgent need to manage and curate this evidence to inform public health, clinical and health-system decision-making. Eager to provide some type of guidance in a scenario of uncertainty, many organizations started developing guidelines to provide recommendations to manage COVID-19 patients. Clinical practice guidelines (CPGs) have been published since the early stages of the pandemic, often in very short time
Abbreviations: AGREE, Appraisal of Guidelines for REsearch & Evaluation; COVID-19, Coronavirus disease of 2019; COVID-END, COVID-19 Evidence Network to support Decision-making; CPG, Clinical Practice Guidelines; GRADE-ADOLOPMENT’, Approach to guideline production combines adoption …